MDA-MB-231 adenocarcinoma cells were treated with 25 nM final concentration of siRNA and Lullaby reagent for 72 h before analysis.
This article demonstrates the high efficiency of Lullaby, a transfection reagent from OZ Biosciences to induce gene silencing into breast cancer cell lines.article reference: Proc Natl Acad Sci U S A. 2014 Apr 21.
Control of MT1-MMP transport by atypical PKC during breast-cancer progression.
Rossé C, Lodillinsky C, Fuhrmann L, Nourieh M, Monteiro P, Irondelle M, Lagoutte E, Vacher S, Waharte F, Paul-Gilloteaux P, Romao M, Sengmanivong L, Linch M, van Lint J, Raposo G, Vincent-Salomon A, Bièche I, Parker PJ, Chavrier P.
Abstract
Dissemination of
carcinoma cells requires the pericellular degradation of the
extracellular matrix, which is mediated by membrane type 1-matrix
metalloproteinase (MT1-MMP). In this article, we report a
co-up-regulation and colocalization of MT1-MMP and atypical protein
kinase C iota (aPKCι) in hormone receptor-negative breast tumors in
association with a higher risk of metastasis. Silencing of aPKC in
invasive breast-tumor cell lines impaired the delivery of MT1-MMP from
late endocytic storage compartments to the surface and inhibited matrix
degradation and invasion. We provide evidence that aPKCι, in association
with MT1-MMP-containing endosomes, phosphorylates cortactin, which is
present in F-actin-rich puncta on MT1-MMP-positive endosomes and
regulates cortactin association with the membrane scission protein
dynamin-2. Thus, cell line-based observations and clinical data reveal
the concerted activity of aPKC, cortactin, and dynamin-2, which control
the trafficking of MT1-MMP from late endosome to the plasma membrane and
play an important role in the invasive potential of breast-cancer
cells.
No comments:
Post a Comment